Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Von Hippel-Lindau Disease”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Early research (Phase 1)Active Not RecruitingNCT04895748
What this trial is testing

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 40
Large-scale testing (Phase 3)Study completedNCT01865747
What this trial is testing

Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 658
Not applicableLooking for participantsNCT05424016
What this trial is testing

Propranolol and Von Hippel-Lindau Disease

Who this might be right for
Hemangioblastoma of CNSVon Hippel-Lindau Disease
Assistance Publique - Hôpitaux de Paris 85
Not applicableStudy completedNCT00970970
What this trial is testing

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more
University Medical Center Groningen 22
Not applicableUnknownNCT02207686
What this trial is testing

Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?

Who this might be right for
Von Hippel-Lindaus Disease
Marie Luise Bisgaard, MD 50
Testing effectiveness (Phase 2)Study completedNCT01967537
What this trial is testing

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsVon Hippel-Lindau SyndromeHippel-Lindau Disease
National Cancer Institute (NCI) 341
Not applicableStudy completedNCT00001668
What this trial is testing

Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors

Who this might be right for
DeafnessKidney DiseasesKidney Neoplasms+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 75
Not applicableStudy completedNCT02120040
What this trial is testing

Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System

Who this might be right for
Hemangioblastoma (HB) of the Central Nervous System (CNS)
Assistance Publique Hopitaux De Marseille 42
Not applicableLooking for participantsNCT06195150
What this trial is testing

Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaVHL Syndrome
IRCCS San Raffaele 3
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Not applicableLooking for participantsNCT01496625
What this trial is testing

National Eye Institute Biorepository for Retinal Diseases

Who this might be right for
Age-Related Macular DegenerationDiabetic RetinopathyVon Hippel-Lindau Syndrome+2 more
National Eye Institute (NEI) 650
Very early researchEnded earlyNCT03001349
What this trial is testing

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

Who this might be right for
MeningiomaMetastatic Well Differentiated Neuroendocrine NeoplasmMultiple Endocrine Neoplasia Type 1+3 more
M.D. Anderson Cancer Center 4
Not applicableStudy completedNCT00062166
What this trial is testing

Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau Disease
National Cancer Institute (NCI) 340
Very early researchEnded earlyNCT01015300
What this trial is testing

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Who this might be right for
HemangioblastomasVon Hippel Lindau Disease
Dartmouth-Hitchcock Medical Center 1
Testing effectiveness (Phase 2)Ended earlyNCT01266070
What this trial is testing

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Who this might be right for
Von Hippel-Lindau Syndrome
M.D. Anderson Cancer Center 6
Early research (Phase 1)Study completedNCT02108002
What this trial is testing

Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)

Who this might be right for
Von Hippel-Lindau Disease
National Institute of Neurological Disorders and Stroke (NINDS) 7
Early research (Phase 1)Study completedNCT00056199
What this trial is testing

EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Hippel-Lindau Disease
National Eye Institute (NEI) 5
Large-scale testing (Phase 3)Not Yet RecruitingNCT07405164
What this trial is testing

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

Who this might be right for
Von Hippel-Lindau DiseaseCarcinoma, Renal Cell
Merck Sharp & Dohme LLC 450
Early research (Phase 1)Study completedNCT00089765
What this trial is testing

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Von Hippel-Lindau Syndrome
National Eye Institute (NEI) 5
Testing effectiveness (Phase 2)Looking for participantsNCT04924075
What this trial is testing

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Who this might be right for
Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more
Merck Sharp & Dohme LLC
Load More Results
322